XXII
22nd Century·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 7
Ample Liquidity
Negative Gross Margin
Significant Revenue Decline
Significant Net Income Growth
Low Cash Short-term Debt Ratio
Price Hits New Low
Price Hits 52-week Low
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About XXII
22nd Century Group, Inc
A leading agricultural biotech company that develops products focused on reducing tobacco harm and smokig cessation
Biological Technology
09/12/2005
08/16/2021
NASDAQ Stock Exchange
56
12-31
Common stock
321 Farmington Road, Mocksville, North Carolina 27028
--
22nd Century Group, Inc was incorporated under the laws of the State of Nevada on September 12, 2005 as Touchstone Mining Limited. 22nd Century Limited, LLC. The Company is a tobacco products company that sells and distributes proprietary novel reduced nicotine tobacco products authorized by the FDA as modified risk tobacco products.
Earnings Call
Q1/2025
Estimate EPS--
Actual EPS-1.89
Estimate Revenue--
Actual Revenue5.96M
Conflicting Signals: 22nd Century's Q1 2025 Earnings Call Unveils Breakeven Timeline and CMO Revenue Challenges
May 20,2025 10:55
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS--
Actual EPS-13.16
Estimate Revenue--
Actual Revenue4.08M
22nd Century Group's Q2 2025 Earnings Call: Unpacking Contradictions in Breakeven Goals, Cash Position, and Revenue Projections
Aug 14,2025 10:50
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
XXII has released its 2025 Q3 earnings. EPS was reported at -1.06, versus the expected -16.79, beating expectations. The chart below visualizes how XXII has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
XXII has released its 2025 Q3 earnings report, with revenue of 4.01M, reflecting a YoY change of -32.54%, and net profit of 5.49M, showing a YoY change of 246.10%. The Sankey diagram below clearly presents XXII's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
